Asian Phytoceuticals PCLBKK:APCO-R 62 EBITDA Margin % is 54.74% as of Mar. 2026, which is 24% above its 10-year median of 44.14. GuruFocus rates BKK:APCO-R with a GF Score™ of 62/100 and a GF Value™ of ฿7.46. The stock has 4 warning signs investors should review. Among 1,953 Consumer Packaged Goods companies, Asian Phytoceuticals PCL ranks better than 97.59% on this metric.
Asian Phytoceuticals PCL (BKK:APCO-R) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Asian Phytoceuticals PCL EBITDA Margin % Related Terms
Asian Phytoceuticals PCL EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:APCO-R vs PG, CL, KVUE: EBITDA Margin % Comparison
For the Household & Personal Products subindustry, Asian Phytoceuticals PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asian Phytoceuticals PCL EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Asian Phytoceuticals PCL's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Asian Phytoceuticals PCL's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asian Phytoceuticals PCL (BKK:APCO-R) has a EBITDA Margin % of 54.74% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Asian Phytoceuticals PCL and its competitors. This is 24% above median its historical median of 44.14. Over the past decade, Asian Phytoceuticals PCL's EBITDA Margin % has ranged from 33.01 to 53.28. According to the industry distribution chart, Asian Phytoceuticals PCL ranks #47 out of 1953 companies in the Consumer Packaged Goods industry, placing it in the top 2.4%.
Is Asian Phytoceuticals PCL's EBITDA Margin % too high?
Asian Phytoceuticals PCL's current EBITDA Margin % of 54.74% is 24% above median its 10-year median of 44.14. Over the past 10 years, this metric has ranged from a low of 33.01 to a high of 53.28. The Consumer Packaged Goods industry median EBITDA Margin % is 9.00. Asian Phytoceuticals PCL's value of 54.74% is 508.2% above this industry median. Based on the distribution chart, Asian Phytoceuticals PCL ranks #47 out of 1953 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Asian Phytoceuticals PCL has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Asian Phytoceuticals PCL's EBITDA Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Asian Phytoceuticals PCL ranks #47 out of 1953 companies for EBITDA Margin %. This places Asian Phytoceuticals PCL in the top 2% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.00. Asian Phytoceuticals PCL's value of 54.74% is 508.2% above this benchmark. Historically, Asian Phytoceuticals PCL's own EBITDA Margin % has ranged from 33.01 to 53.28 over the past decade. While the company's 10-year median is 44.14 vs. the industry median of 9.00, Asian Phytoceuticals PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 9.00, based on 1,953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asian Phytoceuticals PCL's current EBITDA Margin % of 54.74% is 508.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Asian Phytoceuticals PCL and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 9.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asian Phytoceuticals PCL's current EBITDA Margin % is 54.74%, which is 24% above median its own 10-year median of 44.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asian Phytoceuticals PCL stock overvalued right now?
Asian Phytoceuticals PCL (BKK:APCO-R) has a current EBITDA Margin % of 54.74%. The stock's GF Value™ is ฿7.46, compared to a current price of ฿6.27 — trading 15.9% below its estimated fair value. The current EBITDA Margin % is 54.74%, which is 24% above median its 10-year median of 44.14 and 508.2% above the Consumer Packaged Goods industry median of 9.00. Asian Phytoceuticals PCL's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Asian Phytoceuticals PCL (BKK:APCO-R), the current EBITDA Margin % is 54.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asian Phytoceuticals PCL (BKK:APCO-R) Overvalued in 2026?
Based on GuruFocus' analysis, Asian Phytoceuticals PCL stock appears to be undervalued.
The current stock price of ฿6.27 is trading 15.9% below its estimated GF Value™ of ฿7.46.
Key valuation signals for BKK:APCO-R:
EBITDA Margin %: 54.74% (24% above median its 10-year median of 44.14)
GF Value™: ฿7.46 vs. price of ฿6.27 (15.9% below fair value)
Industry Position: 508.2% above the Consumer Packaged Goods median (#47 of 1953)
No single metric tells the full story. See the BKK:APCO-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
62GF Score
Get the complete analysis for BKK:APCO-R
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:APCO-R has been successfully added to your 
